The North America Virtual Clinical Trials Market would witness market growth of 4.8% CAGR during the forecast period (2020-2026). The market is significantly driven by growth in R&D activities, the growing digitization in healthcare, and the adoption of telehealth. Moreover, advances in technology, collaborations between clinical research companies, biotechnology companies, and pharmaceutical and support initiatives from governments are expected to boost the market.
The patient-centric approach is followed by a virtual trial, permitting for a better traditional trail experience for the participants together with improved data collection, expanded diversity of patients, and time savings from the view of the trial duration. The virtual trial takes full benefit of the majority of digital instruments available and is defined by no physical visits to a trail site. There is no dearth of terms of labels that are being used to explain the notion of virtual trails. From virtual to mobile-enabled, to remote, to advance, to modern era clinical trials, to adaptable, to digitally-enabled, to software-enabled, to site-less, to direct-to-patient, and the list goes on.
The outbreak of the Covid-19 pandemic is compelling the clinical trial industry to change the process of performing ongoing or upcoming trials. The year 2020 has changed the lives of people upside down. The lockdown guidelines are being observed across the world and the clinical trial industry is no exception to this.
Based on Study Type, the market is segmented into Interventional, Observational, and Expanded Access and Others. Based on Indication, the market is segmented into Oncology, Cardiovascular, Immunology, Gastrointestinal, Respiratory, Endocrinology, Ophthalmology and Other Indications. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: Virtual Clinical Trials Market in North America is expected to register a CAGR of 4.8% during the forecast period (2020-2026)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include IQVIA Holdings, Inc., ICON PLC, Laboratory Corporation of America Holdings (Covance, Inc.), Dassault Systemes SE (Medidata Solutions, Inc.), Oracle Corporation, Parexel International Corporation (Pamplona Capital Management), PRA Health Sciences, Inc. (KKR & Co., Inc.), Medpace Holdings, Inc., Medable, Inc. and Clinical Ink, Inc. (G.I. Partners)
Scope of the Study
Market Segments Covered in the Report:
By Study Type
- Interventional
- Observational
- Expanded Access
- Others
By Indication
- Oncology
- Cardiovascular
- Immunology
- Gastrointestinal
- Respiratory
- Endocrinology
- Ophthalmology
- Other Indications
By Country
- US
- Canada
- Mexico
- Rest of North America
Companies Profiled
- IQVIA Holdings, Inc.
- ICON PLC
- Laboratory Corporation of America Holdings (Covance, Inc.)
- Dassault Systemes SE (Medidata Solutions, Inc.)
- Oracle Corporation
- Parexel International Corporation (Pamplona Capital Management)
- PRA Health Sciences, Inc. (KKR & Co., Inc.)
- Medpace Holdings, Inc.
- Medable, Inc.
- Clinical Ink, Inc. (G.I. Partners)
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Virtual Clinical Trials Market, by Study Type
1.4.2 North America Virtual Clinical Trials Market, by Indication
1.4.3 North America Virtual Clinical Trials Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Oct – 2020, Nov) Leading Players
3.3.3 Key Strategic Move: (Product Launches and Product Expansions : 2018, Jun – 2020, Oct) Leading Players
Chapter 4. North America Virtual Clinical Trials Market by Study Type
4.1 North America Interventional Market by Country
4.2 North America Observational Market by Country
4.3 North America Expanded Access Market by Country
Chapter 5. North America Virtual Clinical Trials Market by Indication
5.1 North America Oncology Market by Country
5.2 North America Cardiovascular Market by Country
5.3 North America Immunology Market by Country
5.4 North America Gastrointestinal Market by Country
5.5 North America Respiratory Market by Country
5.6 North America Endocrinology Market by Country
5.7 North America Ophthalmology Market by Country
5.8 North America Other Indications Market by Country
Chapter 6. North America Virtual Clinical Trials Market by Country
6.1 US Virtual Clinical Trials Market
6.1.1 US Virtual Clinical Trials Market by Study Type
6.1.2 US Virtual Clinical Trials Market by Indication
6.2 Canada Virtual Clinical Trials Market
6.2.1 Canada Virtual Clinical Trials Market by Study Type
6.2.2 Canada Virtual Clinical Trials Market by Indication
6.3 Mexico Virtual Clinical Trials Market
6.3.1 Mexico Virtual Clinical Trials Market by Study Type
6.3.2 Mexico Virtual Clinical Trials Market by Indication
6.4 Rest of North America Virtual Clinical Trials Market
6.4.1 Rest of North America Virtual Clinical Trials Market by Study Type
6.4.2 Rest of North America Virtual Clinical Trials Market by Indication
Chapter 7. Company Profiles
7.1 IQVIA Holdings, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Recent strategies and developments:
7.1.4.1 Partnerships, Collaborations, and Agreements:
7.1.4.2 Product Launches and Product Expansions:
7.2 ICON PLC
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.1 Recent strategies and developments:
7.2.1.1 Partnerships, Collaborations, and Agreements:
7.2.1.2 Product Launches and Product Expansions:
7.2.1.3 Acquisition and Mergers:
7.3 Laboratory Corporation of America Holdings (Covance, Inc.)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Recent strategies and developments:
7.3.4.1 Product Launches and Product Expansions:
7.3.4.2 Acquisition and Mergers:
7.4 Dassault Systemes SE (Medidata Solutions, Inc.)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Partnerships, Collaborations, and Agreements:
7.4.5.2 Product Launches and Product Expansions:
7.4.5.3 Acquisition and Mergers:
7.5 Oracle Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.5.5.2 Product Launches and Product Expansions:
7.6 Parexel International Corporation (Pamplona Capital Management)
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Partnerships, Collaborations, and Agreements:
7.6.2.2 Product Launches and Product Expansions:
7.6.2.3 Geographical Expansions:
7.7 PRA Health Sciences, Inc. (KKR & Co., Inc.)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental Analysis
7.7.4 Recent strategies and developments:
7.7.4.1 Partnerships, Collaborations, and Agreements:
7.7.4.2 Product Launches and Product Expansions:
7.8 Medpace Holdings, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Recent strategies and developments:
7.8.3.1 Partnerships, Collaborations, and Agreements:
7.9 Medable, Inc.
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Partnerships, Collaborations, and Agreements:
7.9.2.2 Product Launches and Product Expansions:
7.10. Clinical Ink, Inc. (G.I. Partners)
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Partnerships, Collaborations, and Agreements:
TABLE 1 North America Virtual Clinical Trials Market, 2016 - 2019, USD Million
TABLE 2 North America Virtual Clinical Trials Market, 2020 - 2026, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Virtual Clinical Trials Market
TABLE 4 Product Launches And Product Expansions– Virtual Clinical Trials Market
TABLE 5 Geographical Expansions – Virtual Clinical Trials Market
TABLE 6 Acquisition and Mergers– Virtual Clinical Trials Market
TABLE 7 North America Virtual Clinical Trials Market by Study Type, 2016 - 2019, USD Million
TABLE 8 North America Virtual Clinical Trials Market by Study Type, 2020 - 2026, USD Million
TABLE 9 North America Interventional Market by Country, 2016 - 2019, USD Million
TABLE 10 North America Interventional Market by Country, 2020 - 2026, USD Million
TABLE 11 North America Observational Market by Country, 2016 - 2019, USD Million
TABLE 12 North America Observational Market by Country, 2020 - 2026, USD Million
TABLE 13 North America Expanded Access Market by Country, 2016 - 2019, USD Million
TABLE 14 North America Expanded Access Market by Country, 2020 - 2026, USD Million
TABLE 15 North America Virtual Clinical Trials Market by Indication, 2016 - 2019, USD Million
TABLE 16 North America Virtual Clinical Trials Market by Indication, 2020 - 2026, USD Million
TABLE 17 North America Oncology Market by Country, 2016 - 2019, USD Million
TABLE 18 North America Oncology Market by Country, 2020 - 2026, USD Million
TABLE 19 North America Cardiovascular Market by Country, 2016 - 2019, USD Million
TABLE 20 North America Cardiovascular Market by Country, 2020 - 2026, USD Million
TABLE 21 North America Immunology Market by Country, 2016 - 2019, USD Million
TABLE 22 North America Immunology Market by Country, 2020 - 2026, USD Million
TABLE 23 North America Gastrointestinal Market by Country, 2016 - 2019, USD Million
TABLE 24 North America Gastrointestinal Market by Country, 2020 - 2026, USD Million
TABLE 25 North America Respiratory Market by Country, 2016 - 2019, USD Million
TABLE 26 North America Respiratory Market by Country, 2020 - 2026, USD Million
TABLE 27 North America Endocrinology Market by Country, 2016 - 2019, USD Million
TABLE 28 North America Endocrinology Market by Country, 2020 - 2026, USD Million
TABLE 29 North America Ophthalmology Market by Country, 2016 - 2019, USD Million
TABLE 30 North America Ophthalmology Market by Country, 2020 - 2026, USD Million
TABLE 31 North America Other Indications Market by Country, 2016 - 2019, USD Million
TABLE 32 North America Other Indications Market by Country, 2020 - 2026, USD Million
TABLE 33 North America Virtual Clinical Trials Market by Country, 2016 - 2019, USD Million
TABLE 34 North America Virtual Clinical Trials Market by Country, 2020 - 2026, USD Million
TABLE 35 US Virtual Clinical Trials Market, 2016 - 2019, USD Million
TABLE 36 US Virtual Clinical Trials Market, 2020 - 2026, USD Million
TABLE 37 US Virtual Clinical Trials Market by Study Type, 2016 - 2019, USD Million
TABLE 38 US Virtual Clinical Trials Market by Study Type, 2020 - 2026, USD Million
TABLE 39 US Virtual Clinical Trials Market by Indication, 2016 - 2019, USD Million
TABLE 40 US Virtual Clinical Trials Market by Indication, 2020 - 2026, USD Million
TABLE 41 Canada Virtual Clinical Trials Market, 2016 - 2019, USD Million
TABLE 42 Canada Virtual Clinical Trials Market, 2020 - 2026, USD Million
TABLE 43 Canada Virtual Clinical Trials Market by Study Type, 2016 - 2019, USD Million
TABLE 44 Canada Virtual Clinical Trials Market by Study Type, 2020 - 2026, USD Million
TABLE 45 Canada Virtual Clinical Trials Market by Indication, 2016 - 2019, USD Million
TABLE 46 Canada Virtual Clinical Trials Market by Indication, 2020 - 2026, USD Million
TABLE 47 Mexico Virtual Clinical Trials Market, 2016 - 2019, USD Million
TABLE 48 Mexico Virtual Clinical Trials Market, 2020 - 2026, USD Million
TABLE 49 Mexico Virtual Clinical Trials Market by Study Type, 2016 - 2019, USD Million
TABLE 50 Mexico Virtual Clinical Trials Market by Study Type, 2020 - 2026, USD Million
TABLE 51 Mexico Virtual Clinical Trials Market by Indication, 2016 - 2019, USD Million
TABLE 52 Mexico Virtual Clinical Trials Market by Indication, 2020 - 2026, USD Million
TABLE 53 Rest of North America Virtual Clinical Trials Market, 2016 - 2019, USD Million
TABLE 54 Rest of North America Virtual Clinical Trials Market, 2020 - 2026, USD Million
TABLE 55 Rest of North America Virtual Clinical Trials Market by Study Type, 2016 - 2019, USD Million
TABLE 56 Rest of North America Virtual Clinical Trials Market by Study Type, 2020 - 2026, USD Million
TABLE 57 Rest of North America Virtual Clinical Trials Market by Indication, 2016 - 2019, USD Million
TABLE 58 Rest of North America Virtual Clinical Trials Market by Indication, 2020 - 2026, USD Million
TABLE 59 Key information – IQVIA Holdings, Inc.
TABLE 60 Key Information – ICON PLC
TABLE 61 Key Information – Laboratory Corporation of America holdings
TABLE 62 Key Information – Dassault Systemes SE
TABLE 63 Key Information – Oracle Corporation
TABLE 64 Key Information – PAREXEL International Corporation
TABLE 65 Key Information – PRA Health Sciences, Inc.
TABLE 66 key Information – Medpace Holdings, Inc.
TABLE 67 Key Information – Medable, Inc.
TABLE 68 Key Information – Clinical Ink, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2016-2020)
FIG 4 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Feb – 2020, Dec) Leading Players
FIG 5 Key Strategic Move: (Product Launches and Product Expansions : 2018, Jun – 2020, Oct) Leading Players
FIG 6 Recent strategies and developments: IQVIA Holdings, Inc.
FIG 7 Recent strategies and developments: ICON PLC
FIG 8 Recent strategies and developments: Laboratory Corporation of America
FIG 9 Recent strategies and developments: Dassault Systemes SE
FIG 10 Recent strategies and developments: Oracle Corporation
FIG 11 Recent strategies and developments: Parexel International Corporation
FIG 12 Recent strategies and developments: PRA Health Sciences, Inc.
FIG 13 Recent strategies and developments: Medable, Inc.